Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model

BACKGROUND: Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism that has poor pharmacokinetic properties,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Hee, Lee, Gha Young, Maeng, Hyo Jin, Kim, Hoyoun, Bae, Jae Hyun, Kim, Kyoung Min, Lim, Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937856/
https://www.ncbi.nlm.nih.gov/pubmed/33677937
http://dx.doi.org/10.3803/EnM.2020.781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937856/
https://www.ncbi.nlm.nih.gov/pubmed/33677937
http://dx.doi.org/10.3803/EnM.2020.781

Ejemplares similares